Consistent with previous studies, showing reduced levels of GH and IGF- 1 in case of NAFLD [13,14] and obesity [10], our study population showed decreased circulating amounts of GH and IGF- 1 in obese subjects with FLI values higher than 60. This evidence concerns the gene GH1 and metabolic dysfunction-associated steatotic liver disease.